Published in Arch Surg on August 01, 2004
Staging of cutaneous melanoma. Ann Oncol (2009) 1.26
Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res (2010) 1.01
PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol (2012) 0.90
Head and neck melanoma. ISRN Surg (2012) 0.89
Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors. World J Surg Oncol (2013) 0.83
Outcomes for lymph node-positive cutaneous melanoma over two decades. World J Surg (2011) 0.83
Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma. Melanoma Res (2011) 0.76
Controversies in the diagnosis and treatment of early cutaneous melanoma. J Med Life (2015) 0.75
Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma. Dermatol Res Pract (2012) 0.75
Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med (2014) 10.69
Formation of regulatory patterns during signal propagation in a Mammalian cellular network. Science (2005) 3.48
The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A (2005) 3.05
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history. J Clin Oncol (2007) 2.99
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol (2008) 2.95
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke (2004) 2.76
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma. J Clin Oncol (2007) 2.19
The role of microsatellites as a prognostic factor in primary malignant melanoma. Arch Dermatol (2005) 2.17
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (2006) 2.00
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol (2012) 1.92
The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst (2013) 1.76
Pityriasis rosea: an important papulosquamous disorder. Int J Dermatol (2005) 1.76
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. Rheumatology (Oxford) (2009) 1.68
Innovation in surgery: a historical perspective. Ann Surg (2006) 1.66
Perineural spread of malignant melanoma of the head and neck: clinical and imaging features. AJNR Am J Neuroradiol (2004) 1.65
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res (2004) 1.64
Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol (2006) 1.64
miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem (2011) 1.63
Management of significant venous discrepancy with microvascular venous coupler. J Reconstr Microsurg (2003) 1.52
Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg (2005) 1.47
Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition. J Clin Oncol (2012) 1.45
Getting to better cancer care: results of a society of surgical oncology survey. Ann Surg Oncol (2008) 1.37
Melanoma. J Natl Compr Canc Netw (2009) 1.37
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med (2009) 1.31
Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci U S A (2006) 1.27
The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol (2005) 1.26
Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol (2010) 1.26
Sunitinib therapy for melanoma patients with KIT mutations. Clin Cancer Res (2012) 1.23
Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis. Cancer Biother Radiopharm (2009) 1.20
Osteopontin as a molecular prognostic marker for melanoma. Cancer (2008) 1.20
Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis (2005) 1.19
Cutaneous melanoma: prognostic factors. Cancer Control (2005) 1.13
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol (2012) 1.11
Melanoma arising in African-, Asian-, Latino- and Native-American populations. Semin Cutan Med Surg (2009) 1.11
Novel role for RGS1 in melanoma progression. Am J Surg Pathol (2008) 1.10
Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression. Proc Natl Acad Sci U S A (2010) 1.07
Propionyl-CoA and adenosylcobalamin metabolism in Caenorhabditis elegans: evidence for a role of methylmalonyl-CoA epimerase in intermediary metabolism. Mol Genet Metab (2006) 1.06
An excess of chromosome 1 breakpoints in male infertility. Eur J Hum Genet (2004) 1.06
Prospective evaluation of peritoneal fluid contamination following transabdominal vs. transanal specimen extraction in laparoscopic left-sided colorectal resections. Surg Endosc (2011) 1.04
Successful extracorporeal membrane oxygenation treatment for pheochromocytoma-induced acute cardiac failure. Am J Emerg Med (2011) 1.03
Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma. J Clin Oncol (2006) 1.02
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. Hum Gene Ther (2007) 1.02
Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. Nucl Med Commun (2007) 1.02
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies. Clin Cancer Res (2009) 1.01
Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol (2002) 1.01
Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet (2007) 1.01
A multimarker prognostic assay for primary cutaneous melanoma. Clin Cancer Res (2009) 1.01
Validation of a 2-day water maze protocol in mice. Behav Brain Res (2008) 0.99
Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children. J Am Acad Dermatol (2013) 0.99
Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol (2013) 0.98
Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol (2010) 0.98
Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys (2009) 0.98
Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clin Cancer Res (2004) 0.97
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol (2011) 0.97
Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol (2004) 0.96
CurrMIT: a tool for managing medical school curricula. Acad Med (2003) 0.95
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012". J Transl Med (2013) 0.95
Inventing our future: training the next generation of surgeon innovators. Semin Pediatr Surg (2006) 0.95
Cutaneous melanoma: a model to study cancer metastasis. J Surg Oncol (2011) 0.94
Sagittal and coronal dimensions of the ethmoid roof: a radioanatomic study. Am J Rhinol (2005) 0.94
Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? Ann Surg Oncol (2013) 0.94
Functional modulation of IGF-binding protein-3 expression in melanoma. J Invest Dermatol (2010) 0.94
Loss of the eukaryotic initiation factor 3f in melanoma. Mol Carcinog (2008) 0.94
Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. Oncologist (2009) 0.94
Prognostic factors in primary cutaneous melanoma. Surg Clin North Am (2003) 0.93
Profiling surgical staplers: effect of staple height, buttress, and overlap on staple line failure. Surg Obes Relat Dis (2008) 0.93
Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck (2006) 0.93
Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders. Biol Psychiatry (2009) 0.92
Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family. Proc Natl Acad Sci U S A (2003) 0.92
Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. J Am Acad Dermatol (2003) 0.92
Detection of impaired cerebral autoregulation improves by increasing arterial blood pressure variability. J Cereb Blood Flow Metab (2012) 0.91
A prospective randomized trial of ultrasound- vs landmark-guided central venous access in the pediatric population. J Am Coll Surg (2013) 0.91
Biomarkers for melanoma. Curr Opin Oncol (2005) 0.90
Dosimetry characterization of a multibeam radiotherapy treatment for age-related macular degeneration. Med Phys (2008) 0.89
Identification of the lateral position of a virtual object based on echoes by humans. Hear Res (2013) 0.89
Giant cutaneous melanomas: evidence for primary tumour induced dormancy in metastatic sites? BMJ Case Rep (2009) 0.88
Casein kinase 1 suppresses activation of REST in insulted hippocampal neurons and halts ischemia-induced neuronal death. J Neurosci (2014) 0.88
Progression of cutaneous melanoma: implications for treatment. Clin Exp Metastasis (2012) 0.87
Ribozymes in the age of molecular therapeutics. Curr Mol Med (2004) 0.87
Estimation of out-of-plane vertebra rotations on radiographic projections using CT data: a simulation study. Med Eng Phys (2002) 0.87
24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging (2012) 0.87
Prognostic factors in patients with thick cutaneous melanoma (> 4 mm). Cancer (2002) 0.86
Prognostic significance of extent of ulceration in primary cutaneous melanoma. Am J Surg Pathol (2006) 0.86
Laparo-endoscopic single-site (LESS) with transanal natural orifice specimen extraction (NOSE) sigmoidectomy: a new step before pure colorectal natural orifices transluminal endoscopic surgery (NOTES®). J Gastrointest Surg (2011) 0.86
Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia. Metabolism (2005) 0.85
Analysis of sentinel lymph node positivity in patients with thin primary melanoma. J Am Acad Dermatol (2012) 0.85
Telomerase: going beyond the ends. Cell Cycle (2007) 0.85
Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma. J Clin Oncol (2005) 0.85
Quality measurement in cancer care delivery. Ann Surg Oncol (2011) 0.84
Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis. Am J Pathol (2009) 0.84
Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites. Clin Nucl Med (2005) 0.84